Diagnosis and management of AML in adults: 2022 …
2022年9月22日 · These advances have prompted this update that includes a revised ELN genetic risk classification, revised response criteria, and treatment recommendations. Since the 2017 …
Diagnosis and management of AML in adults: 2022 ... - PubMed
2022年9月22日 · The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults …
2022 ELN recommendations for the diagnosis of AML in adults
2022年9月8日 · In NPM1 -mutated and core-binding factor AML, quantitative polymerase chain reaction (PCR) or a droplet digital PCR is recommended to monitor measurable residual …
ELN Recommendations - LeukemiaNet
The most visible results of the ELN are the guidelines and management recommendations for virtually every leukemia and interdisciplinary speciality which have lain the groundwork for …
Comparison and validation of the 2022 European LeukemiaNet …
2023年5月9日 · Risk stratification in acute myeloid leukemia (AML) remains principle in survival prognostication and treatment selection. The 2022 European LeukemiaNet (ELN) …
Comparison and validation of the 2022 European LeukemiaNet
2023年5月9日 · Risk stratification in acute myeloid leukemia (AML) remains principle in survival prognostication and treatment selection. The 2022 European LeukemiaNet (ELN) …
Diagnosis and management of AML in adults: 2017 ELN …
2017年1月26日 · The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults, published in 2010, has …
Refined ELN 2024 risk stratification improves survival ... - PubMed
2024年12月26日 · The European LeukemiaNet 2024 risk-stratification guidelines for patients with acute myeloid leukemia receiving hypomethylating agents combined with venetoclax were …
Validation and refinement of the 2022 European LeukemiaNet
2023年4月11日 · We studied 1118 newly diagnosed AML patients (median age, 58 years; range, 18–86 years) who received cytarabine-based induction chemotherapy between 1999 and …
Validation of the Revised 2022 European LeukemiaNet Risk …
2024年11月6日 · In 2022, the European LeukemiaNet (ELN) risk stratification for patients with AML has been updated. We aimed to validate the prognostic value of the 2022 ELN …